IRIS
DE MICHELE, GIUSEPPE
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
AS - Asia 10.631
NA - Nord America 9.792
EU - Europa 8.884
SA - Sud America 1.529
AF - Africa 303
OC - Oceania 18
Continente sconosciuto - Info sul continente non disponibili 8
Totale 31.165
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 9.383
SG - Singapore 6.014
RU - Federazione Russa 4.359
CN - Cina 2.130
BR - Brasile 1.262
IT - Italia 1.204
HK - Hong Kong 1.046
VN - Vietnam 742
DE - Germania 651
FI - Finlandia 561
NL - Olanda 501
UA - Ucraina 432
GB - Regno Unito 260
CA - Canada 248
IE - Irlanda 247
IN - India 206
SE - Svezia 167
AR - Argentina 124
FR - Francia 118
ZA - Sudafrica 117
MX - Messico 113
ES - Italia 82
BD - Bangladesh 79
PL - Polonia 73
CI - Costa d'Avorio 69
JP - Giappone 52
IQ - Iraq 50
TR - Turchia 44
BE - Belgio 39
AT - Austria 38
KR - Corea 35
EC - Ecuador 30
CO - Colombia 28
ID - Indonesia 28
LT - Lituania 23
VE - Venezuela 22
AE - Emirati Arabi Uniti 21
IR - Iran 21
PK - Pakistan 20
CL - Cile 17
NP - Nepal 17
UZ - Uzbekistan 16
PY - Paraguay 15
UY - Uruguay 15
BG - Bulgaria 14
EG - Egitto 14
CZ - Repubblica Ceca 13
IL - Israele 13
GR - Grecia 12
PT - Portogallo 12
AZ - Azerbaigian 11
PH - Filippine 11
AU - Australia 10
KE - Kenya 10
LB - Libano 10
MA - Marocco 10
JO - Giordania 9
SN - Senegal 9
TN - Tunisia 9
CR - Costa Rica 8
DK - Danimarca 8
DZ - Algeria 8
ET - Etiopia 8
PE - Perù 8
RO - Romania 8
KZ - Kazakistan 7
MK - Macedonia 7
MY - Malesia 7
AL - Albania 6
BO - Bolivia 6
DO - Repubblica Dominicana 6
EU - Europa 6
SI - Slovenia 6
RS - Serbia 5
SA - Arabia Saudita 5
UG - Uganda 5
BA - Bosnia-Erzegovina 4
BB - Barbados 4
BW - Botswana 4
CH - Svizzera 4
EE - Estonia 4
LU - Lussemburgo 4
LV - Lettonia 4
MD - Moldavia 4
NO - Norvegia 4
TH - Thailandia 4
TT - Trinidad e Tobago 4
YE - Yemen 4
AO - Angola 3
DM - Dominica 3
GM - Gambi 3
GT - Guatemala 3
JM - Giamaica 3
KG - Kirghizistan 3
KW - Kuwait 3
MN - Mongolia 3
MU - Mauritius 3
PS - Palestinian Territory 3
AM - Armenia 2
BF - Burkina Faso 2
Totale 31.082
Salva come PNG Salva come JPEG
Città #
Singapore 2.658
Chandler 1.245
Moscow 1.061
Hong Kong 1.045
Ashburn 842
Beijing 661
Millbury 453
Jacksonville 439
Amsterdam 417
Santa Clara 398
Princeton 365
Los Angeles 300
Ho Chi Minh City 265
Nanjing 264
Munich 259
Dallas 254
Naples 241
Hefei 188
Boston 182
Buffalo 168
Wilmington 155
Napoli 152
Hanoi 131
New York 130
Redondo Beach 124
Helsinki 118
Ottawa 117
São Paulo 115
The Dalles 107
Seattle 103
San Jose 97
Nanchang 89
Turku 88
Des Moines 87
Houston 84
Woodbridge 82
Chicago 75
Shenyang 66
Warsaw 62
Denver 61
Mexico City 60
Hebei 59
Dong Ket 58
Jiaxing 58
Columbus 56
Norwalk 56
Nuremberg 55
London 52
Brooklyn 51
Johannesburg 51
Chennai 50
Montreal 49
Orem 47
Tianjin 45
Rio de Janeiro 43
Atlanta 42
Tokyo 41
Toronto 38
Rome 36
Changsha 35
Poplar 35
Washington 34
Falls Church 33
Phoenix 32
Redwood City 32
Boardman 31
Shanghai 30
Stockholm 30
Frankfurt am Main 29
San Mateo 29
Lawrence 28
Augusta 27
Belo Horizonte 27
Biên Hòa 26
Kunming 26
Pune 26
Seoul 25
Da Nang 24
Dublin 24
Haiphong 24
Kronberg 24
Ankara 22
Porto Alegre 22
Dhaka 21
Ninh Bình 21
Manchester 20
Milan 20
Brasília 19
Querétaro 19
Vienna 19
Falkenstein 18
Nola 18
San Francisco 18
Brussels 17
Guangzhou 17
Guarulhos 17
Hải Dương 17
Mumbai 17
New Delhi 17
Goiânia 16
Totale 15.681
Salva come PNG Salva come JPEG
Nome #
A case of restless leg syndrome in a family with LRRK2 gene mutation. 258
Alteration of endosomal trafficking is associated with early-onset parkinsonism caused by SYNJ1 mutations 184
Alteration of endosomal trafficking is associated with neurodegenerative diseases 169
Pelizaeus-Merzbacher-Like disease presentation of MCT8 mutated male subjects. 167
Screening of ARHSP-TCC patients expands the spectrum of SPG11 mutations and includes a large scale gene deletion. 167
Diagnostic issues faced by a rare disease healthcare network during Covid-19 outbreak: data from the Campania Rare Disease Registry 162
Cognitive decline in Huntington's disease expansion gene carriers 157
Reduced Cancer Incidence in Huntington's Disease: Analysis in the Registry Study 154
Brain structural damage in Friedreich's ataxia. 153
Identification of genetic variants associated with Huntington's disease progression: a genome-wide association study 151
Epoetin alfa increases frataxin production in Friedreich's ataxia without affecting hematocrit. 149
Modifications of resting state networks in spinocerebellar ataxia type 2 148
DNA damage signatures in peripheral blood cells as biomarkers in prodromal huntington disease 142
The Italian version of the quick mild cognitive impairment (Qmci-I) screen: normative study on 307 healthy subjects 137
Ataxia with oculomotor apraxia type 1 in southern italy: late onset and variable phenotype. 136
A randomized controlled pilot trial of lithium in spinocerebellar ataxia type 2. 136
Parkinsonism in adult-onset Rasmussens's encephalitis: a clinical picture presenting as corticobasal syndrome 135
Influence of GAA expansion size and disease duration on Central Nervous System impairment in Friedreich's Ataxia. Contribution to the understanding of the pathophysiology of the disease 134
Emotion Recognition and Psychological Comorbidity in Friedreich’s Ataxia 132
Electrophysiological characterisation in hereditary spastic paraplegia type 5. 131
Long-term effect of epoetin alfa on clinical and biochemical markers in friedreich ataxia 131
CCM3/PDCD10 gene mutation in cerebral cavernous malformations associated with hyperkeratotic cutaneous capillary venous malformations 131
Benign hereditary chorea: clinical and neuroimaging features in an Italian family. 130
SPG5 and multiple sclerosis: clinical and genetic overlap? 130
Pathological laughter as onset symptom in atypical parkinsonisms 129
Impulsive-compulsive behaviors in parkin-associated Parkinson disease 128
A double-blind cross-over trial of amantadine hydrochloride in Friedreich's ataxia. 128
Prevalence and features of non-motor symptoms in Wilson's disease 127
Complex phenotype in an Italian family with a novel mutation in SPG3A. 126
Imaging of dopaminergic dysfunction with [123I]FP-CIT SPECT in early-onset parkin disease. 126
CAG repeat expansion in Huntington disease determines age at onset in a fully dominant fashion. 126
Screening for Fabry disease in a series of Parkinson’s disease patients and literature review 125
Closing-in Phenomenon in Huntington's Disease: A Neuropsychological Marker of Frontal/Executive Dysfunction 125
Cerebellar blood flow in spinocerebellar degenerations: a single photon emission tomography study in 28 patients. 124
Normal and mutant HTT interact to affect clinical severity and progression in Huntington disease. 123
Be aware of Wolfram syndrome when examining ataxic patients 123
Non-motor symptoms and cardiac innervation in SYNJ1-related parkinsonism 122
Variable phenotype in a P102L Gerstmann-Straussler-Scheinker Italian family 121
Auditory function and speech discrimination abilities are impaired in progressive supranuclear palsy 121
DNA damage induced by polyglutamine-expanded proteins. 120
A randomized controlled clinical trial of growth hormone in amyotrophic lateral sclerosis: clinical, neuroimaging, and hormonal results. 120
Gender differences in non-motor symptoms in early, drug naïve Parkinson's disease 120
Chronic Pachymeningitis: a case of neurosyphilis with spastic paraparesis. 119
The Heterogeneity of Early Parkinson?s Disease: A Cluster Analysis on Newly Diagnosed Untreated Patients 119
NMDA receptor gene variations as modifiers in Huntington disease: a replication study. 119
Perseverative Behavior on Verbal Fluency Task in Patients with Huntington's Disease: a Retrospective Study on a Large Patient Sample 119
Short-term continuous infusion of apomorphine hydrochloride for treatment of Huntington's chorea: A double blind, randomized cross-over trial 118
Electrophysiologic characterization in spinocerebellar ataxia 17 118
PINK1 homozygous W437X mutation in a patient with apparent dominant transmission of parkinsonism. 118
Suicidal ideation in a European Huntington's disease population. 118
Long-term clinical experience with weekly interferon beta-1a in relapsing multiple sclerosis 117
Autosomal dominant cerebellar ataxia type I: multimodal electrophysiological study and comparison between SCA1 and SCA2 patients 117
Very late onset in ataxia oculomotor apraxia type I. 117
Chorea-acanthocytosis without chorea: Expanding the clinical phenotype 117
Serum epidermal growth factor predicts cognitive functions in early, drug-naive Parkinson's disease patients. 117
Autonomic disorders and myocardial 123I-metaiodobenzylguanidine scintigraphy in Huntington's disease 117
Primary familial brain calcification caused by a novel homozygous MYORG mutation in a consanguineous Italian family. 116
Ataxia with oculomotor apraxia type 1 in Southern Italy: late onset and variable phenotype 115
Relative frequencies of CAG expansions in spinocerebellar ataxia and dentatorubropallidoluysian atrophy in 116 Italian families 115
Ataxia with oculomotor apraxia type 2: a clinical, pathologic, and genetic study 115
Novel mutation of SACS gene in a Spanish family with autosomal recessive spastic ataxia 115
Reduced striatal [123I]FP-CIT binding in SCA2 patients without parkinsonism 115
Cutaneous sensory and autonomic denervation in Progressive Supranuclear Palsy 115
Frontal defect contribution to decreasing of body mass index in Parkinson's disease patients 114
Why do some Friedreich's ataxia patients retain tendon reflexes? A clinical, neurophysiological and molecular study. 114
Characterization of nigrostriatal dysfunction in spinocerebellar ataxia 17 113
Progression of striatal and extrastriatal degeneration in multiple system atrophy: a longitudinal diffusion-weighted MR study. 113
Genetic screening for LRRK2 gene G2019S mutation in Parkinson's disease patients from Southern Italy. 113
Application of the p9NORM correction method to timed neuropsychological tests in Parkinson's disease and multiple system atrophy. 113
The Effect of Cerebellar Degeneration on Human Sensori-motor Plasticity 112
Adult normative values for the PATA Rate Test 112
Mutational analysis of the PINK1 gene in early-onset parkinsonism in Europe and North Africa. 111
A randomized trial of varenicline (Chantix) for the treatment of spinocerebellar ataxia type 3. 111
Efficacy of dopamine agonist treatment in delayed-onset parkinsonism due to midbrain hemorrhage. 111
A randomized clinical trial of lithium in multiple system atrophy. 110
Peripheral markers of autophagy in polyglutamine diseases 110
Predictors of survival in spinocerebellar ataxia type 2 population from Southern Italy. 110
Longitudinal study of a cohort of MSA-C patients in South Italy: survival and clinical features 110
A refined physical and transcriptional map of the SPG9 locus on 10q23.3[#150]q24.2 109
Stability of erythropoietin repackaging in polypropylene syringes for clinical use 109
Animal-Assisted Therapy in Elderly Patients: Evidence and Controversies in Dementia and Psychiatric Disorders and Future Perspectives in Other Neurological Diseases 109
Default-Mode Network Changes in Huntington's Disease: An Integrated MRI Study of Functional Connectivity and Morphometry. 108
The flavor test is a sensitive tool in identifying the flavor sensorineural dysfunction in Parkinson's disease 108
Powerhouse failure and oxidative damage in autosomal recessive spastic ataxia of Charlevoix-Saguenay 107
Variable phenotype in a P102L Gerstmann-Sträussler-Scheinker Italian family. 106
Reversible valproate-induced subacute encephalopathy associated with a MT-ATP8 variant in the mitochondrial genome 106
Assessment of non-motor and autonomic symptoms in Wilson's disease patients 106
Motor and non-motor features in Parkinson's Disease patients carrying GBA gene mutations 105
Cognitive profile and 18F-fluorodeoxyglucose PET study in LRRK2-related Parkinson's disease 105
Mild cognitive impairment in drug-naive patients with PD is associated with cerebral hypometabolism. 105
Autosomal recessive progressive myoclonus epilepsy with ataxia and mental retardation. 105
Somatosensory Temporal Discrimination Threshold Is Increased in Patients with Cerebellar Atrophy. 105
Normalization of timed neuropsychological tests with the PATA rate and nine-hole pegboard tests 105
Mutations in the SPAST gene causing hereditary spastic paraplegia arerelated to global topological alterations in brain functional networks 104
A double-blind, cross-over trial with madopar HBS in patients with Parkinson's disease. 103
Insulin Sensitivity and Early-Phase Insulin Secretion in Normoglycemic Huntington's Disease Patients 103
Myocardial (123)I-metaiodobenzylguanidine scintigraphy in patients with homozygous and heterozygous parkin mutations 103
Spinocerebellar ataxia type 48: last but not least 103
Antiphospholipid-related chorea. 102
Metabolic Ataxias in Adults. 102
Totale 12.309
Salva come PNG Salva come JPEG
Categoria #
all - tutte 111.089
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 111.089
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021625 0 0 0 0 0 0 105 51 124 33 231 81
2021/20222.046 45 19 17 30 26 56 29 88 274 187 375 900
2022/20232.911 444 249 89 253 335 306 20 216 402 427 131 39
2023/20241.784 87 248 242 141 97 159 40 281 10 28 324 127
2024/20259.963 526 555 44 91 286 430 1.054 661 964 992 3.490 870
2025/202610.991 2.108 1.143 1.813 1.721 3.261 833 112 0 0 0 0 0
Totale 31.773